Carmela Cursaro
About
In The Last Decade
Carmela Cursaro
94 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 91
- Hepatology 1.6k
- Epidemiology 1.4k
- Oncology 214
- Surgery 202
- Immunology 195
Countries citing papers authored by Carmela Cursaro
This map shows the geographic impact of Carmela Cursaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmela Cursaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmela Cursaro more than expected).
Fields of papers citing papers by Carmela Cursaro
This network shows the impact of papers produced by Carmela Cursaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmela Cursaro. The network helps show where Carmela Cursaro may publish in the future.
Co-authorship network of co-authors of Carmela Cursaro
This figure shows the co-authorship network connecting the top 25 collaborators of Carmela Cursaro. A scholar is included among the top collaborators of Carmela Cursaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmela Cursaro. Carmela Cursaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 10 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 7 | |
| 9 | 5 | |
| 10 | 330 | |
| 11 | 16 | |
| 12 | 61 | |
| 13 | 39 | |
| 14 | 14 | |
| 15 | 13 | |
| 16 | 60 | |
| 17 | Hepatitis C virus infection and lymphoproliferative disorders. | 6 |
| 18 | Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis | 4 |
| 19 | 73 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.